Mattias Collin
71 – 80 of 108
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Enzymatically Generated Low Carbohydrate Antibodies as a Novel Treatment for Autoimmune Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Human IgG/FcgammaR Interactions Are Modulated by Streptococcal IgG Glycan Hydrolysis.
(
- Contribution to journal › Article
-
Mark
The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial
(
- Contribution to journal › Article
-
Mark
The Antibacterial Chemokine MIG/CXCL9 Is Constitutively Expressed in Epithelial Cells of the Male Urogenital Tract and Is Present in Seminal Plasma.
(
- Contribution to journal › Article
-
Mark
Constitutive expression of the antibacterial CXC chemokine GCP-2/CXCL6 by epithelial cells of the male reproductive tract.
(
- Contribution to journal › Article
-
Mark
In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner
(
- Contribution to journal › Article
-
Mark
EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.
(
- Contribution to journal › Article
- 2007
-
Mark
Endoglycosidase treatment abrogates IgG arthritogenicity: Importance of IgG glycosylation in arthritis.
(
- Contribution to journal › Article
-
Mark
M1 protein of Streptococcus pyogenes increases production of the antibacterial CXC chemokine MIG/CXCL9 in pharyngeal epithelial cells
(
- Contribution to journal › Article